Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis

Background: We previously identified a 12-microRNA (miRNA) panel (miRNA-17, miRNA-146a, miRNA-200b, miRNA-182, miRNA-155, miRNA-221, miRNA-205, miRNA-126, miRNA-7, miRNA-21, miRNA-145, and miRNA-210) that aided in the early diagnosis of non-small cell lung cancer (NSCLC). We validated the diagnostic...

Full description

Bibliographic Details
Main Authors: Weidong Wang, Dongni Chen, Weiwei Chen, Ziya Xin, Zirui Huang, Xuewen Zhang, Kexing Xi, Gongming Wang, Rusi Zhang, Dechang Zhao, Li Liu, Lanjun Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00855/full
_version_ 1819106696463646720
author Weidong Wang
Weidong Wang
Weidong Wang
Dongni Chen
Dongni Chen
Weiwei Chen
Weiwei Chen
Ziya Xin
Ziya Xin
Zirui Huang
Zirui Huang
Xuewen Zhang
Xuewen Zhang
Kexing Xi
Gongming Wang
Gongming Wang
Rusi Zhang
Rusi Zhang
Dechang Zhao
Dechang Zhao
Li Liu
Li Liu
Lanjun Zhang
Lanjun Zhang
author_facet Weidong Wang
Weidong Wang
Weidong Wang
Dongni Chen
Dongni Chen
Weiwei Chen
Weiwei Chen
Ziya Xin
Ziya Xin
Zirui Huang
Zirui Huang
Xuewen Zhang
Xuewen Zhang
Kexing Xi
Gongming Wang
Gongming Wang
Rusi Zhang
Rusi Zhang
Dechang Zhao
Dechang Zhao
Li Liu
Li Liu
Lanjun Zhang
Lanjun Zhang
author_sort Weidong Wang
collection DOAJ
description Background: We previously identified a 12-microRNA (miRNA) panel (miRNA-17, miRNA-146a, miRNA-200b, miRNA-182, miRNA-155, miRNA-221, miRNA-205, miRNA-126, miRNA-7, miRNA-21, miRNA-145, and miRNA-210) that aided in the early diagnosis of non-small cell lung cancer (NSCLC). We validated the diagnostic value of this miRNA panel and compared it with that of traditional tumor markers and radiological diagnosis. We constructed a nomogram based on the miRNA panel's results to predict the risk of NSCLC.Methods: Eighty-two participants with pulmonary nodules on a CT scan and who underwent a pathological examination and surgical treatment were enrolled in our study. Patients were randomly divided into a training group or a validation group. The miRNA concentrations were quantified by RT-PCR and log-transformed for analysis. The cutoff value was determined in the training group and then applied in the validation group. A comparison between the miRNAs and traditional tumor markers [CEA, NSE, and cytokeratin 19 fragment 21-1 (Cyfra21-1)] and radiological diagnosis was performed. A nomogram based on the miRNA panel's results to predict the risk of NSCLC was constructed.Results: The expression level of these 12 miRNAs was significantly higher in NSCLC patients than in benign patients. In the validation group, the specificity and positive predictive value were 96.4 and 95.8%, respectively, which were significantly higher than those using traditional tumor markers or radiological diagnosis. The sensitivity was 42.6%, which was also higher than that using tumor markers. Moreover, the sensitivity increased to 63.6% when the nodule diameters were larger than 2 cm. The miRNAs and seven clinical factors were integrated into the nomogram, and the calibration curves showed optimal agreement between the predicted and actual probabilities.Conclusions: Our miRNA panel has clinical value for the early detection of NSCLC. A nomogram was constructed and internally validated, and the results indicate that it can assist clinicians in making treatment recommendations in the clinic.
first_indexed 2024-12-22T02:42:15Z
format Article
id doaj.art-55eb4739eb7c4fb98b196a0ae27cd669
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-22T02:42:15Z
publishDate 2020-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-55eb4739eb7c4fb98b196a0ae27cd6692022-12-21T18:41:36ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-06-011010.3389/fonc.2020.00855536123Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant DiagnosisWeidong Wang0Weidong Wang1Weidong Wang2Dongni Chen3Dongni Chen4Weiwei Chen5Weiwei Chen6Ziya Xin7Ziya Xin8Zirui Huang9Zirui Huang10Xuewen Zhang11Xuewen Zhang12Kexing Xi13Gongming Wang14Gongming Wang15Rusi Zhang16Rusi Zhang17Dechang Zhao18Dechang Zhao19Li Liu20Li Liu21Lanjun Zhang22Lanjun Zhang23Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Anesthesiology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Colorectal Surgery, Peking Union Medical College, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaDepartment of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaBackground: We previously identified a 12-microRNA (miRNA) panel (miRNA-17, miRNA-146a, miRNA-200b, miRNA-182, miRNA-155, miRNA-221, miRNA-205, miRNA-126, miRNA-7, miRNA-21, miRNA-145, and miRNA-210) that aided in the early diagnosis of non-small cell lung cancer (NSCLC). We validated the diagnostic value of this miRNA panel and compared it with that of traditional tumor markers and radiological diagnosis. We constructed a nomogram based on the miRNA panel's results to predict the risk of NSCLC.Methods: Eighty-two participants with pulmonary nodules on a CT scan and who underwent a pathological examination and surgical treatment were enrolled in our study. Patients were randomly divided into a training group or a validation group. The miRNA concentrations were quantified by RT-PCR and log-transformed for analysis. The cutoff value was determined in the training group and then applied in the validation group. A comparison between the miRNAs and traditional tumor markers [CEA, NSE, and cytokeratin 19 fragment 21-1 (Cyfra21-1)] and radiological diagnosis was performed. A nomogram based on the miRNA panel's results to predict the risk of NSCLC was constructed.Results: The expression level of these 12 miRNAs was significantly higher in NSCLC patients than in benign patients. In the validation group, the specificity and positive predictive value were 96.4 and 95.8%, respectively, which were significantly higher than those using traditional tumor markers or radiological diagnosis. The sensitivity was 42.6%, which was also higher than that using tumor markers. Moreover, the sensitivity increased to 63.6% when the nodule diameters were larger than 2 cm. The miRNAs and seven clinical factors were integrated into the nomogram, and the calibration curves showed optimal agreement between the predicted and actual probabilities.Conclusions: Our miRNA panel has clinical value for the early detection of NSCLC. A nomogram was constructed and internally validated, and the results indicate that it can assist clinicians in making treatment recommendations in the clinic.https://www.frontiersin.org/article/10.3389/fonc.2020.00855/fullnon-small cell lung cancermiRNAnomogramliquid biopsyearly diagnosis
spellingShingle Weidong Wang
Weidong Wang
Weidong Wang
Dongni Chen
Dongni Chen
Weiwei Chen
Weiwei Chen
Ziya Xin
Ziya Xin
Zirui Huang
Zirui Huang
Xuewen Zhang
Xuewen Zhang
Kexing Xi
Gongming Wang
Gongming Wang
Rusi Zhang
Rusi Zhang
Dechang Zhao
Dechang Zhao
Li Liu
Li Liu
Lanjun Zhang
Lanjun Zhang
Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
Frontiers in Oncology
non-small cell lung cancer
miRNA
nomogram
liquid biopsy
early diagnosis
title Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
title_full Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
title_fullStr Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
title_full_unstemmed Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
title_short Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
title_sort early detection of non small cell lung cancer by using a 12 microrna panel and a nomogram for assistant diagnosis
topic non-small cell lung cancer
miRNA
nomogram
liquid biopsy
early diagnosis
url https://www.frontiersin.org/article/10.3389/fonc.2020.00855/full
work_keys_str_mv AT weidongwang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT weidongwang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT weidongwang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT dongnichen earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT dongnichen earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT weiweichen earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT weiweichen earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT ziyaxin earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT ziyaxin earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT ziruihuang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT ziruihuang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT xuewenzhang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT xuewenzhang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT kexingxi earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT gongmingwang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT gongmingwang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT rusizhang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT rusizhang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT dechangzhao earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT dechangzhao earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT liliu earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT liliu earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT lanjunzhang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis
AT lanjunzhang earlydetectionofnonsmallcelllungcancerbyusinga12micrornapanelandanomogramforassistantdiagnosis